Subsidiary Guarantors for Credit Agreement, Term Loan and 2021 Notes - Condensed Consolidated Statements (Details) - USD ($)	12 Months Ended
	Oct. 28, 2016	Oct. 30, 2015	Oct. 31, 2014	Oct. 25, 2013
Condensed Consolidating Statement of Income
Net sales	$ 2,371,400,000	$ 3,172,147,000	$ 3,778,310,000
Cost of sales	1,855,574,000	2,333,225,000	2,654,233,000
Product development, selling and administrative expenses	476,684,000	583,218,000	587,289,000
Goodwill impairment charges	0	1,199,256,000	0
Restructuring and other impairment charges	89,896,000	172,440,000	21,597,000
Other (income) expense	(9,342,000)	(6,603,000)	(12,335,000)
Operating (loss) income	(41,412,000)	(1,109,389,000)	527,526,000
Intercompany items	0	0	0
Loss on early debt retirement	0	(14,311,000)	0
Interest (expense) income, net	(45,759,000)	(53,429,000)	(55,348,000)
(Loss) income from continuing operations before income taxes	(87,171,000)	(1,177,129,000)	472,178,000
(Benefit) provision for income taxes	(23,326,000)	875,000	134,060,000
Equity in (loss) income of subsidiaries	0	0	0
(Loss) income from continuing operations	(63,845,000)	(1,178,004,000)	338,118,000
Comprehensive (loss) income	(57,058,000)	(1,318,796,000)	301,810,000
Current assets:
Cash and cash equivalents	276,709,000	102,885,000
Accounts receivable, net	683,958,000	812,073,000
Inventories	814,821,000	1,007,925,000
Other current assets	113,877,000	145,559,000
Assets held for sale	3,703,000	0
Total current assets	1,893,068,000	2,068,442,000
Property, plant and equipment, net	656,245,000	792,032,000
Other assets:
Other intangible assets, net	223,411,000	255,710,000
Goodwill	350,843,000	354,621,000	1,516,693,000
Deferred income taxes	171,775,000	118,913,000
Other non-current assets	131,089,000	122,728,000
Total other assets	877,118,000	851,972,000
Total assets	3,426,431,000	3,712,446,000	5,592,349,000
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	42,054,000	26,321,000
Trade accounts payable	236,787,000	275,789,000
Employee compensation and benefits	91,224,000	90,335,000
Advance payments and progress billings	173,121,000	229,470,000
Accrued warranties	40,787,000	52,146,000	67,272,000
Other accrued liabilities	188,591,000	225,277,000
Current liabilities of discontinued operations	0	11,582,000
Total current liabilities	772,564,000	910,920,000
Long-term obligations	964,979,000	1,060,643,000
Other liabilities:
Liabilities for postretirement benefits	14,260,000	19,540,000
Accrued pension costs	175,120,000	175,699,000
Other non-current liabilities	117,802,000	125,635,000
Total other liabilities	307,182,000	320,874,000
Shareholders’ equity	1,381,706,000	1,420,009,000	2,836,360,000	$ 2,855,311,000
Total liabilities and shareholders’ equity	3,426,431,000	3,712,446,000
Operating Activities:
Net cash provided (used) by operating activities of continuing operations	253,641,000	355,333,000	363,441,000
Net cash provided (used) by operating activities of discontinued operations	0	0	(102,000)
Net cash provided by operating activities	253,641,000	355,333,000	363,339,000
Investing Activities:
Acquisition of businesses, net of cash acquired	0	(114,353,000)	(44,426,000)
Property, plant and equipment acquired	(42,690,000)	(71,336,000)	(91,077,000)
Proceeds from sale of business	28,250,000	0	0
Proceeds from sale of property, plant and equipment	24,838,000	4,300,000	9,963,000
Other investing activities, net	(744,000)	(83,000)	53,000
Net cash provided (used) by investing activities	9,654,000	(181,472,000)	(125,487,000)
Financing Activities:
Common stock issued	639,000	4,654,000	13,346,000
Dividends paid	(3,984,000)	(77,950,000)	(74,945,000)
Redemption of 6% note due 2016	0	(250,000,000)	0
Repayments of Term Loan	(18,750,000)	0	(37,500,000)
(Payments) borrowings on Credit Agreement	(58,600,000)	58,600,000	0
Financing fees	(1,011,000)	0	(2,826,000)
Treasury stock purchased	0	(50,000,000)	(269,336,000)
Other financing activities, net	(2,984,000)	(10,260,000)	3,964,000
Net cash used by financing activities	(84,690,000)	(324,956,000)	(367,297,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3,271,000)	(16,211,000)	(6,073,000)
Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	175,334,000	(167,306,000)	(135,518,000)
Cash, Cash Equivalents and Restricted Cash at Beginning of Year	102,885,000	270,191,000	405,709,000
Cash, Cash Equivalents and Restricted Cash at End of Year	278,219,000	102,885,000	270,191,000
Credit Agreement, Term Loan, and Senior Notes due 2021 [Member] | Reportable Legal Entities [Member] | Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0	0
Cost of sales	0	0	700,000
Product development, selling and administrative expenses	58,923,000	47,604,000	60,942,000
Goodwill impairment charges		0
Restructuring and other impairment charges	395,000	0	0
Other (income) expense	0	68,000	(473,000)
Operating (loss) income	(59,318,000)	(47,672,000)	(61,169,000)
Intercompany items	55,152,000	66,408,000	64,185,000
Loss on early debt retirement		(14,311,000)
Interest (expense) income, net	(50,031,000)	(63,138,000)	(63,639,000)
(Loss) income from continuing operations before income taxes	(54,197,000)	(58,713,000)	(60,623,000)
(Benefit) provision for income taxes	(24,165,000)	(3,807,000)	(46,296,000)
Equity in (loss) income of subsidiaries	(28,347,000)	(1,123,098,000)	352,445,000
(Loss) income from continuing operations	(58,379,000)	(1,178,004,000)	338,118,000
Comprehensive (loss) income	(57,058,000)	(1,318,796,000)	301,810,000
Current assets:
Cash and cash equivalents	131,344,000	581,000
Accounts receivable, net	3,000	0
Inventories	0	0
Other current assets	6,418,000	58,441,000
Assets held for sale	0
Total current assets	137,765,000	59,022,000
Property, plant and equipment, net	18,521,000	21,318,000
Other assets:
Other intangible assets, net	0	0
Goodwill	0	0
Deferred income taxes	154,267,000	49,660,000
Other non-current assets	2,353,718,000	2,740,518,000
Total other assets	2,507,985,000	2,790,178,000
Total assets	2,664,271,000	2,870,518,000
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	37,500,000	18,750,000
Trade accounts payable	4,013,000	3,342,000
Employee compensation and benefits	8,346,000	5,843,000
Advance payments and progress billings	0	0
Accrued warranties	0	0
Other accrued liabilities	87,958,000	76,650,000
Current liabilities of discontinued operations		0
Total current liabilities	137,817,000	104,585,000
Long-term obligations	964,939,000	1,060,598,000
Other liabilities:
Liabilities for postretirement benefits	14,260,000	18,662,000
Accrued pension costs	175,120,000	159,594,000
Other non-current liabilities	(9,571,000)	81,595,000
Total other liabilities	179,809,000	259,851,000
Shareholders’ equity	1,381,706,000	1,445,484,000
Total liabilities and shareholders’ equity	2,664,271,000	2,870,518,000
Operating Activities:
Net cash provided (used) by operating activities of continuing operations			306,292,000
Net cash provided (used) by operating activities of discontinued operations			0
Net cash provided by operating activities	213,831,000	261,293,000	306,292,000
Investing Activities:
Acquisition of businesses, net of cash acquired		0	0
Property, plant and equipment acquired	(618,000)	(945,000)	(4,706,000)
Proceeds from sale of business	0
Proceeds from sale of property, plant and equipment	0	942,000	0
Other investing activities, net	(744,000)	(1,148,000)	16,000
Net cash provided (used) by investing activities	(1,362,000)	(1,151,000)	(4,690,000)
Financing Activities:
Common stock issued	639,000	4,654,000	13,346,000
Dividends paid	(3,984,000)	(77,950,000)	(74,945,000)
Redemption of 6% note due 2016		(250,000,000)
Repayments of Term Loan	(18,750,000)		(37,500,000)
(Payments) borrowings on Credit Agreement	(58,600,000)	58,600,000
Financing fees	(1,011,000)		(2,826,000)
Treasury stock purchased		(50,000,000)	(269,336,000)
Other financing activities, net	0	261,000	1,632,000
Net cash used by financing activities	(81,706,000)	(314,435,000)	(369,629,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0	0
Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	130,763,000	(54,293,000)	(68,027,000)
Cash, Cash Equivalents and Restricted Cash at Beginning of Year	581,000	54,874,000	122,901,000
Cash, Cash Equivalents and Restricted Cash at End of Year	131,344,000	581,000	54,874,000
Credit Agreement, Term Loan, and Senior Notes due 2021 [Member] | Reportable Legal Entities [Member] | Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	1,165,721,000	1,801,405,000	2,127,333,000
Cost of sales	958,222,000	1,339,541,000	1,542,011,000
Product development, selling and administrative expenses	176,085,000	169,935,000	232,474,000
Goodwill impairment charges		133,413,000
Restructuring and other impairment charges	39,957,000	50,596,000	3,759,000
Other (income) expense	5,065,000	17,534,000	12,667,000
Operating (loss) income	(13,608,000)	90,386,000	336,422,000
Intercompany items	(336,409,000)	(107,484,000)	(77,048,000)
Loss on early debt retirement		0
Interest (expense) income, net	1,920,000	6,769,000	6,750,000
(Loss) income from continuing operations before income taxes	(348,097,000)	(10,329,000)	266,124,000
(Benefit) provision for income taxes	(16,310,000)	17,886,000	155,459,000
Equity in (loss) income of subsidiaries	254,320,000	(39,946,000)	165,942,000
(Loss) income from continuing operations	(77,467,000)	(68,161,000)	276,607,000
Comprehensive (loss) income	(76,876,000)	(69,263,000)	281,569,000
Current assets:
Cash and cash equivalents	21,476,000	2,008,000
Accounts receivable, net	186,332,000	214,381,000
Inventories	377,875,000	508,774,000
Other current assets	5,996,000	15,610,000
Assets held for sale	3,703,000
Total current assets	595,382,000	740,773,000
Property, plant and equipment, net	214,488,000	297,476,000
Other assets:
Other intangible assets, net	187,018,000	207,891,000
Goodwill	341,984,000	346,348,000
Deferred income taxes	0	0
Other non-current assets	1,864,321,000	2,078,294,000
Total other assets	2,393,323,000	2,632,533,000
Total assets	3,203,193,000	3,670,782,000
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	0	0
Trade accounts payable	80,848,000	96,891,000
Employee compensation and benefits	28,363,000	36,527,000
Advance payments and progress billings	69,174,000	100,312,000
Accrued warranties	16,909,000	19,027,000
Other accrued liabilities	38,376,000	60,228,000
Current liabilities of discontinued operations		11,582,000
Total current liabilities	233,670,000	324,567,000
Long-term obligations	0	0
Other liabilities:
Liabilities for postretirement benefits	0	878,000
Accrued pension costs	0	8,406,000
Other non-current liabilities	9,832,000	8,325,000
Total other liabilities	9,832,000	17,609,000
Shareholders’ equity	2,959,691,000	3,328,606,000
Total liabilities and shareholders’ equity	3,203,193,000	3,670,782,000
Operating Activities:
Net cash provided (used) by operating activities of continuing operations			3,418,000
Net cash provided (used) by operating activities of discontinued operations			(102,000)
Net cash provided by operating activities	(17,962,000)	16,105,000	3,316,000
Investing Activities:
Acquisition of businesses, net of cash acquired		0	0
Property, plant and equipment acquired	(8,883,000)	(19,108,000)	(23,130,000)
Proceeds from sale of business	28,250,000
Proceeds from sale of property, plant and equipment	18,063,000	216,000	6,512,000
Other investing activities, net	0	0	(1,052,000)
Net cash provided (used) by investing activities	37,430,000	(18,892,000)	(17,670,000)
Financing Activities:
Common stock issued	0	0	0
Dividends paid	0	0	0
Redemption of 6% note due 2016		0
Repayments of Term Loan	0		0
(Payments) borrowings on Credit Agreement	0	0
Financing fees	0		0
Treasury stock purchased		0	0
Other financing activities, net	0	(11,634,000)	10,422,000
Net cash used by financing activities	0	(11,634,000)	10,422,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	0	0
Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	19,468,000	(14,421,000)	(3,932,000)
Cash, Cash Equivalents and Restricted Cash at Beginning of Year	2,008,000	16,429,000	20,361,000
Cash, Cash Equivalents and Restricted Cash at End of Year	21,476,000	2,008,000	16,429,000
Credit Agreement, Term Loan, and Senior Notes due 2021 [Member] | Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	1,887,270,000	2,330,469,000	2,568,580,000
Cost of sales	1,435,313,000	1,732,574,000	1,876,783,000
Product development, selling and administrative expenses	242,399,000	365,653,000	293,873,000
Goodwill impairment charges		1,065,843,000
Restructuring and other impairment charges	49,544,000	121,844,000	17,838,000
Other (income) expense	(14,407,000)	(24,205,000)	(24,529,000)
Operating (loss) income	174,421,000	(931,240,000)	404,615,000
Intercompany items	105,867,000	48,415,000	(29,099,000)
Loss on early debt retirement		0
Interest (expense) income, net	2,352,000	2,940,000	1,541,000
(Loss) income from continuing operations before income taxes	282,640,000	(879,885,000)	377,057,000
(Benefit) provision for income taxes	17,149,000	(13,204,000)	24,897,000
Equity in (loss) income of subsidiaries	0	0	0
(Loss) income from continuing operations	265,491,000	(866,681,000)	352,160,000
Comprehensive (loss) income	286,431,000	(1,019,963,000)	311,369,000
Current assets:
Cash and cash equivalents	123,889,000	100,296,000
Accounts receivable, net	515,418,000	597,826,000
Inventories	502,162,000	607,461,000
Other current assets	101,463,000	71,508,000
Assets held for sale	0
Total current assets	1,242,932,000	1,377,091,000
Property, plant and equipment, net	427,645,000	478,253,000
Other assets:
Other intangible assets, net	36,393,000	47,819,000
Goodwill	8,859,000	8,273,000
Deferred income taxes	17,508,000	69,253,000
Other non-current assets	3,049,371,000	2,517,110,000
Total other assets	3,112,131,000	2,642,455,000
Total assets	4,782,708,000	4,497,799,000
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	4,554,000	7,571,000
Trade accounts payable	151,926,000	175,556,000
Employee compensation and benefits	54,515,000	47,965,000
Advance payments and progress billings	104,427,000	149,795,000
Accrued warranties	23,878,000	33,119,000
Other accrued liabilities	67,801,000	100,660,000
Current liabilities of discontinued operations		0
Total current liabilities	407,101,000	514,666,000
Long-term obligations	40,000	45,000
Other liabilities:
Liabilities for postretirement benefits	0	0
Accrued pension costs	0	7,699,000
Other non-current liabilities	117,541,000	35,715,000
Total other liabilities	117,541,000	43,414,000
Shareholders’ equity	4,258,026,000	3,939,674,000
Total liabilities and shareholders’ equity	4,782,708,000	4,497,799,000
Operating Activities:
Net cash provided (used) by operating activities of continuing operations			53,731,000
Net cash provided (used) by operating activities of discontinued operations			0
Net cash provided by operating activities	57,772,000	77,935,000	53,731,000
Investing Activities:
Acquisition of businesses, net of cash acquired		(114,353,000)	(44,426,000)
Property, plant and equipment acquired	(33,189,000)	(51,283,000)	(63,241,000)
Proceeds from sale of business	0
Proceeds from sale of property, plant and equipment	6,775,000	3,142,000	3,451,000
Other investing activities, net	0	1,065,000	1,089,000
Net cash provided (used) by investing activities	(26,414,000)	(161,429,000)	(103,127,000)
Financing Activities:
Common stock issued	0	0	0
Dividends paid	0	0	0
Redemption of 6% note due 2016		0
Repayments of Term Loan	0		0
(Payments) borrowings on Credit Agreement	0	0
Financing fees	0		0
Treasury stock purchased		0	0
Other financing activities, net	(2,984,000)	1,113,000	(8,090,000)
Net cash used by financing activities	(2,984,000)	1,113,000	(8,090,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3,271,000)	(16,211,000)	(6,073,000)
Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	25,103,000	(98,592,000)	(63,559,000)
Cash, Cash Equivalents and Restricted Cash at Beginning of Year	100,296,000	198,888,000	262,447,000
Cash, Cash Equivalents and Restricted Cash at End of Year	125,399,000	100,296,000	198,888,000
Credit Agreement, Term Loan, and Senior Notes due 2021 [Member] | Eliminations
Condensed Consolidating Statement of Income
Net sales	(681,591,000)	(959,727,000)	(917,603,000)
Cost of sales	(537,961,000)	(738,890,000)	(765,261,000)
Product development, selling and administrative expenses	(723,000)	26,000	0
Goodwill impairment charges		0
Restructuring and other impairment charges	0	0	0
Other (income) expense	0	0	0
Operating (loss) income	(142,907,000)	(220,863,000)	(152,342,000)
Intercompany items	175,390,000	(7,339,000)	41,962,000
Loss on early debt retirement		0
Interest (expense) income, net	0	0	0
(Loss) income from continuing operations before income taxes	32,483,000	(228,202,000)	(110,380,000)
(Benefit) provision for income taxes	0	0	0
Equity in (loss) income of subsidiaries	(225,973,000)	1,163,044,000	(518,387,000)
(Loss) income from continuing operations	(193,490,000)	934,842,000	(628,767,000)
Comprehensive (loss) income	(209,555,000)	1,089,226,000	$ (592,938,000)
Current assets:
Cash and cash equivalents	0	0
Accounts receivable, net	(17,795,000)	(134,000)
Inventories	(65,216,000)	(108,310,000)
Other current assets	0	0
Assets held for sale	0
Total current assets	(83,011,000)	(108,444,000)
Property, plant and equipment, net	(4,409,000)	(5,015,000)
Other assets:
Other intangible assets, net	0	0
Goodwill	0	0
Deferred income taxes	0	0
Other non-current assets	(7,136,321,000)	(7,213,194,000)
Total other assets	(7,136,321,000)	(7,213,194,000)
Total assets	(7,223,741,000)	(7,326,653,000)
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	0	0
Trade accounts payable	0	0
Employee compensation and benefits	0	0
Advance payments and progress billings	(480,000)	(20,637,000)
Accrued warranties	0	0
Other accrued liabilities	(5,544,000)	(12,261,000)
Current liabilities of discontinued operations		0
Total current liabilities	(6,024,000)	(32,898,000)
Long-term obligations	0	0
Other liabilities:
Liabilities for postretirement benefits	0	0
Accrued pension costs	0	0
Other non-current liabilities	0	0
Total other liabilities	0	0
Shareholders’ equity	(7,217,717,000)	(7,293,755,000)
Total liabilities and shareholders’ equity	$ (7,223,741,000)	$ (7,326,653,000)